PL345037A1 - Cyclic somatostatin analogs - Google Patents

Cyclic somatostatin analogs

Info

Publication number
PL345037A1
PL345037A1 PL99345037A PL34503799A PL345037A1 PL 345037 A1 PL345037 A1 PL 345037A1 PL 99345037 A PL99345037 A PL 99345037A PL 34503799 A PL34503799 A PL 34503799A PL 345037 A1 PL345037 A1 PL 345037A1
Authority
PL
Poland
Prior art keywords
somatostatin analogs
cyclic somatostatin
cyclic
analogs
somatostatin
Prior art date
Application number
PL99345037A
Inventor
Thomas D Gordon
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of PL345037A1 publication Critical patent/PL345037A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Toxicology (AREA)
  • Emergency Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
PL99345037A 1998-06-16 1999-06-11 Cyclic somatostatin analogs PL345037A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9818198A 1998-06-16 1998-06-16
US8950398P 1998-06-16 1998-06-16
PCT/US1999/013304 WO1999065942A1 (en) 1998-06-16 1999-06-11 Cyclic somatostatin analogs

Publications (1)

Publication Number Publication Date
PL345037A1 true PL345037A1 (en) 2001-11-19

Family

ID=26780645

Family Applications (1)

Application Number Title Priority Date Filing Date
PL99345037A PL345037A1 (en) 1998-06-16 1999-06-11 Cyclic somatostatin analogs

Country Status (12)

Country Link
EP (1) EP1086131A1 (en)
JP (1) JP2002518409A (en)
CN (1) CN1200000C (en)
AR (1) AR021161A1 (en)
AU (1) AU745493B2 (en)
CA (1) CA2335184A1 (en)
HU (1) HUP0102902A3 (en)
NO (1) NO20006320L (en)
PL (1) PL345037A1 (en)
RU (1) RU2242481C2 (en)
TW (3) TW527361B (en)
WO (1) WO1999065942A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1086086T3 (en) 1998-06-12 2005-01-24 Sod Conseils Rech Applic Imidazolyl derivatives and their use as somatostatin receptor ligands
FR2796945B1 (en) 1999-07-30 2002-06-28 Sod Conseils Rech Applic NOVEL DERIVATIVES OF HYDANTOINS, THIOHYDANTOINS, PYRIMIDINEDIONES AND THIOXOPYRIMIDINONES, PROCESSES FOR THEIR PREPARATION AND THEIR APPLICATION AS MEDICAMENTS
ATE360620T1 (en) 2000-08-01 2007-05-15 Sod Conseils Rech Applic IMIDAZOLE DERIVATIVES
US20040186151A1 (en) * 2003-02-12 2004-09-23 Mjalli Adnan M.M. Substituted azole derivatives as therapeutic agents
WO2006063465A1 (en) * 2004-12-15 2006-06-22 Diamedica Inc. Treatment of insulin resistance by modulating somatostatin using somatostatin receptor antagonists
CN101341129B (en) * 2005-12-14 2011-12-14 布里斯托尔-迈尔斯斯奎布公司 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors
KR20080087817A (en) 2005-12-14 2008-10-01 브리스톨-마이어스 스큅 컴퍼니 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors
NZ607477A (en) 2008-09-26 2014-09-26 Ambrx Inc Non-natural amino acid replication-dependent microorganisms and vaccines
EP2168983A1 (en) 2008-09-30 2010-03-31 Ipsen Pharma New octapeptide compounds and their therapeutic use
JP5535931B2 (en) * 2008-10-27 2014-07-02 武田薬品工業株式会社 Bicyclic compound
CN109104863A (en) 2016-02-09 2018-12-28 克德瑞德风险投资公司 Somatostatin receptor antagonist compound and its application method

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770687A (en) * 1995-06-07 1998-06-23 Peptor Limited Comformationally constrained backbone cyclized somatostatin analogs
US6673927B2 (en) * 1996-02-16 2004-01-06 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. Farnesyl transferase inhibitors

Also Published As

Publication number Publication date
EP1086131A1 (en) 2001-03-28
AU4822399A (en) 2000-01-05
HUP0102902A2 (en) 2002-01-28
JP2002518409A (en) 2002-06-25
WO1999065942A8 (en) 2000-02-17
TW200410986A (en) 2004-07-01
CA2335184A1 (en) 1999-12-23
CN1200000C (en) 2005-05-04
TWI242442B (en) 2005-11-01
NO20006320D0 (en) 2000-12-12
CN1305496A (en) 2001-07-25
WO1999065942A1 (en) 1999-12-23
TW527361B (en) 2003-04-11
HUP0102902A3 (en) 2002-02-28
NO20006320L (en) 2001-02-12
AR021161A1 (en) 2002-07-03
AU745493B2 (en) 2002-03-21
RU2242481C2 (en) 2004-12-20
TWI242441B (en) 2005-11-01

Similar Documents

Publication Publication Date Title
AU8977801A (en) Somatostatin analogues
CZ20011342A3 (en) Cyclic tetrapeptides
IL139885A0 (en) Cyclic boroproline compounds
CZ20012876A3 (en) SP-C analogs
HK1043588A1 (en) Vitamin d analogues
GB9926183D0 (en) LED components
DE69941708D1 (en) PACAP PEPTIDE ANALOGS
EP0996458A4 (en) Sandramycin analogs
AU4524401A (en) Receptor-selective somatostatin analogs
EG23909A (en) Vatamin d, analogs
PL348763A1 (en) Phenyl-substituted cyclic enaminones
IL141276A0 (en) Backbone cyclized radiolabelled somatostatin analogs
PL345037A1 (en) Cyclic somatostatin analogs
GB2337549B (en) Retaining components
ZA985896B (en) Cyclic azapeptides
IL139218A0 (en) 2-aroyl-4-acyl-paclitaxel (taxol) analogs
EP1131343A4 (en) Hydrophilic somatostatin analogs
EP1233774A4 (en) Urotensin-ii analogs
GB9823835D0 (en) Component for vaccine
EP1091754A4 (en) Crosslink-stabilized indolicidin analogs
IL138477A0 (en) Cyclic aminoguanidines
EP1233776A4 (en) Urotensin-ii cyclic analogs
GB9929433D0 (en) Cyclic compound
AU6382999A (en) Somatostatin analogs
TW329729U (en) Cyclic tool

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)